|
![](images/top01.gif)
篇目详细内容 |
【篇名】 |
Stem cell research in hepatocellular carcinoma |
【刊名】 |
Frontiers of Medicine in China |
【刊名缩写】 |
Front. Med. China |
【ISSN】 |
1673-7342 |
【EISSN】 |
1673-7458 |
【DOI】 |
10.1007/s11684-008-0001-6 |
【出版社】 |
Higher Education Press and Springer-Verlag |
【出版年】 |
2008 |
【卷期】 |
2
卷1期 |
【页码】 |
1-4
页,共
4
页 |
【作者】 |
SUN Chengyi;
ZUO Shi;
|
【关键词】 |
liver; carcinoma, hepatocellular; stem cell |
【摘要】 |
The traditional view that adult human liver tumors, mainly hepatocellular carcinoma (HCC), arise from mature cell types has been challenged in recent decades. The results of several studies suggest that HCC can be derived from liver stem cells. There are four levels of cells in the liver stem cell lineage: hepatocytes, hepatic stem cells/oval cells, bone marrow stem cells and hepato-pancreas stem cells. However, whether HCC is resulted from the differentiation block of stem cells and, moreover, which liver stem cell lineage is the source cell of hepatocarcinogenesis remain controversial. In this review, we focus on the current status of liver stem cell research and their roles in carcinogenesis of HCC, in order to explore new approaches for stem cell therapy of HCC. |
|